查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970693

客製化基因合成​​服務市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Custom Gene Synthesis Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球客製化基因合成​​服務市場預計將從 2025 年的 15.9 億美元成長到 2031 年的 26.1 億美元，複合年成長率為 8.61%。

該產業的核心在於雙股DNA分子的新型合成，因此能夠產生無需天然模板的精確基因序列。這項技術是製藥、農業和學術界基因工程的基礎。推動該行業發展的主要動力是生物製藥的快速進步以及個人化醫療和疫苗研發對合成DNA的迫切需求。正如美國基因與細胞治療學會所指出的，到2024年，全球在研基因、細胞和RNA療法將超過4000種，凸顯了該產業對高品質合成遺傳材料的巨大需求。

市場概覽
預測期 2027-2031
市場規模：2025年 15.9億美元
市場規模：2031年 26.1億美元
複合年成長率：2026-2031年 8.61%
成長最快的細分市場 商業
最大的市場 北美洲

儘管市場規模不斷擴大，但在合成長或複雜DNA序列方面仍面臨許多挑戰。使用標準化學方法生產重複結構和高GC含量序列會導致產量降低、錯誤率升高，從而增加成本並延誤生產。這些技術限制阻礙了滿足日益成長的工業需求所需的規模化生產，並且隨著研究人員越來越依賴複雜、無錯的基因構建體進行先進的治療應用，這些限制可能會限制市場的整體成長。

市場促進因素

基因和細胞療法研發的快速發展是全球客製化基因合成​​服務市場的主要驅動力。隨著這些先進治療方法從早期研究階段邁向商業化階段，對高品質、符合GMP規範的合成DNA的需求激增，這些DNA是生產質體、病毒載體和引導RNA所必需的。治療創新領域的快速成長促使人們繼續依賴能夠提供大規模、精準基因建構的合成供應商，以確保患者照護所需材料的供應。監管方面的進展進一步強化了這一趨勢。美國食品藥物管理局（FDA）在2023年核准了創紀錄的七種新的細胞和基因療法，顯示研發管線日趨成熟，市場對可靠合成組成的需求也不斷成長。

同時，自動化和DNA合成平台的技術突破正在克服傳統亞磷醯胺化學的局限性，並提升其市場價值。矽基自動化和酵素合成等新技術能夠快速產生更長、更精確的序列，直接滿足生物藥物研發的需求。這些創新吸引了大量投資以擴大產能；例如，Elegen公司於2024年5月完成B輪資金籌措，籌集3,500萬美元，用於提升其無細胞DNA生產能力。這種技術整合也帶來了財務上的成功，Twist Biosciences公司於2024年11月宣布，其2024會計年度合成生物學業務的收入為1.235億美元。

市場挑戰

合成長而複雜的DNA序列的難度是限制全球客製化基因合成​​服務市場擴充性的主要技術障礙。製造商難以生產具有複雜重複結構和高GC含量的序列，這通常會導致產量降低和錯誤率升高。這些技術限制迫使供應商承擔高昂的生產成本和漫長的交貨週期以確保準確性，最終損害了營運效率。因此，無法快速可靠地交付這些複雜的結構會延誤供應鏈，導致無法充分滿足學術機構和製藥公司等客戶的大量需求，這些客戶需要特定的材料來完成高度敏感的計劃。

這種運作瓶頸導致治療研究的加速發展與合成DNA的供給能力之間存在差距，嚴重阻礙了市場成長。該行業在高效擴大複雜序列生產規模方面面臨的挑戰，限制了其支持那些依賴及時材料供應的、資金充足的研發舉措的能力。根據SynBioBeta預測，到2024年，合成生物學領域的創投將達到122億美元。儘管如此巨大的資金流入顯示工業界對遺傳材料的需求旺盛，但有效合成複雜序列方面持續存在的困難，阻礙了市場充分發揮與這項投資相匹配的成長潛力。

市場趨勢

人工智慧 (AI) 正透過序列增強技術最佳化合成生物學的設計階段，從根本上改變市場格局。人工智慧演算法的日益普及，使得在物理合成之前即可預測結構穩定性並最佳化密碼子利用率，從而有效降低並加速了候選藥物設計、建造和測試週期的失敗率。這種向計算設計的轉變顯著推動了對用於演算法模型物理檢驗的合成構建體的需求。 2024 年 4 月，Xaira Therapeutics 宣布已獲得 10 億美元的資金籌措，用於推動人工智慧驅動的藥物發現。這項巨額投資凸顯了業界對高通量基因合成技術的日益依賴，以檢驗人工智慧產生的蛋白質設計。

同時，DNA資料儲存技術的興起正將市場範圍拓展到傳統生命科學領域之外。隨著全球數位資料產生量超過傳統儲存容量，合成DNA作為一種高密度、耐用的長期儲存媒體正備受關注。這個應用領域正從理論研究轉向商業性化，為合成服務供應商將數位資料編碼到基因序列中開闢了新的途徑。例如，2024年1月，BioMemory公司發布了全球首款商用DNA儲存產品（1千位元組容量），展示了該技術在資料歸檔方面的實用性和早期商業化前景。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球客製化基因合成​​服務市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（小於 1000 bp、1001-3000 bp、3001-5000 bp、5000 bp 或以上）
    • 依應用領域（商業用途、學術研究用途）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美客製化基因合成​​服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲客製化基因合成​​服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區客製化基因合成​​服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲客製化基因合成​​服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲客製化基因合成​​服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球客製化基因合成​​服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • GenScript Biotech Corporation
  • Biomatik Corporation
  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Synbio Technologies LLC
  • Biomol GmbH
  • Eurofins Genomics Germany GmbH
  • BioCat GmbH
  • Azenta US Inc.
  • ProMab Biotechnologies, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19087

The Global Custom Gene Synthesis Service Market is projected to expand from USD 1.59 Billion in 2025 to USD 2.61 Billion by 2031, reflecting a compound annual growth rate of 8.61%. This industry centers on the de novo creation of double-stranded DNA molecules, allowing for the generation of precise genetic sequences independent of natural templates, which is fundamental to genetic engineering in pharmaceuticals, agriculture, and academia. Growth is primarily fueled by the rapid advancement of biologics and the urgent demand for synthetic DNA in personalized medicine and vaccine development. As noted by the American Society of Gene & Cell Therapy, the global pipeline contained over 4,000 gene, cell, and RNA therapies in 2024, highlighting the immense industrial requirement for high-grade synthetic genetic materials.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.59 Billion
Market Size 2031USD 2.61 Billion
CAGR 2026-20318.61%
Fastest Growing SegmentCommercial
Largest MarketNorth America

Despite this expansion, the market faces a substantial hurdle in synthesizing long or complex DNA sequences. Producing sequences with repetitive structures or high GC content via standard chemical methods often leads to lower yields and higher error rates, resulting in increased costs and slower production times. This technical limitation hampers the scalability needed to meet growing industrial demands, potentially restricting broader market growth as researchers increasingly depend on intricate, error-free genetic constructs for sophisticated therapeutic applications.

Market Driver

The rapid progression of gene and cell therapy development serves as a major engine for the Global Custom Gene Synthesis Service Market. As these advanced treatments move from early research phases to commercial availability, there is an intensifying need for high-quality, GMP-grade synthetic DNA essential for manufacturing plasmids, viral vectors, and guide RNAs. This boom in therapeutic innovation fosters a continuous reliance on synthesis vendors to provide precise genetic constructs at scale, ensuring the supply of vital materials for patient care. This trend is reinforced by regulatory achievements; the U.S. Food and Drug Administration (FDA) approved a record seven new cell and gene therapies in 2023, signaling a maturing pipeline and a widening market necessity for dependable synthetic components.

Simultaneously, technological breakthroughs in automation and DNA synthesis platforms are boosting market value by resolving the constraints of conventional phosphoramidite chemistry. Newer techniques, such as silicon-based automation and enzymatic synthesis, allow for the fast generation of longer, high-fidelity sequences, directly meeting the needs of biologics discovery. These innovations are drawing significant investment to expand production capacities; for instance, Elegen raised $35 million in Series B funding in May 2024 to enhance its cell-free DNA manufacturing. This technological integration is driving financial success, as evidenced by Twist Bioscience, which reported in November 2024 that its synthetic biology revenue had increased to $123.5 million for the fiscal year 2024.

Market Challenge

The difficulty of synthesizing long and complex DNA sequences creates a major technical obstacle that limits the scalability of the global custom gene synthesis service market. Manufacturers struggle to produce sequences with intricate repetitive structures or high GC content, issues that frequently lead to diminished yields and elevated error rates. These technical constraints force providers to incur higher production costs and face longer turnaround times to guarantee accuracy, ultimately impairing operational efficiency. As a result, the inability to deliver these complex constructs rapidly and reliably slows the supply chain, hindering vendors from fully meeting the high-volume needs of academic and pharmaceutical clients requiring specific materials for sensitive projects.

This operational bottleneck severely impedes market growth by causing a disconnect between the accelerating speed of therapeutic research and the availability of synthetic DNA. The industry's struggle to efficiently scale the production of complex sequences restricts its ability to support well-financed development initiatives that rely on timely material delivery. According to SynBioBeta, venture investment in the synthetic biology sector hit 12.2 billion dollars in 2024. While this massive capital inflow indicates strong industrial demand for genetic materials, persistent difficulties in effectively synthesizing complex sequences prevent the market from fully realizing its growth potential in proportion to this investment.

Market Trends

Artificial intelligence is fundamentally transforming the market by optimizing the design phase of synthetic biology through sequence enhancement. AI algorithms are increasingly utilized to predict structural stability and optimize codon usage prior to physical synthesis, effectively lowering failure rates and speeding up the design-build-test cycle for therapeutic candidates. This shift toward computational design is driving significant demand for synthetic constructs needed to physically validate algorithmic models. In April 2024, Xaira Therapeutics announced it had secured $1 billion in committed capital to further AI-driven drug discovery, a massive investment that highlights the industry's growing dependence on high-throughput gene synthesis to verify protein designs generated by AI.

In parallel, the rise of DNA data storage is broadening the market's reach beyond traditional life sciences. With global digital data production exceeding conventional storage capabilities, synthetic DNA is gaining traction as a high-density, durable medium for long-term archiving. This application is moving from theoretical research to commercial viability, opening a new avenue for synthesis providers to encode digital data into genetic sequences. For example, in January 2024, Biomemory launched the world's first commercially available DNA storage product with a 1-kilobyte capacity, proving the practical feasibility and initial commercialization of this technology for archival needs.

Key Market Players

  • GenScript Biotech Corporation
  • Biomatik Corporation
  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Synbio Technologies LLC
  • Biomol GmbH
  • Eurofins Genomics Germany GmbH
  • BioCat GmbH
  • Azenta US Inc.
  • ProMab Biotechnologies, Inc.

Report Scope

In this report, the Global Custom Gene Synthesis Service Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Custom Gene Synthesis Service Market, By Type

  • Below 1000 bp
  • 1001 to 3000 bp
  • 3001 to 5000 bp
  • above 5000 bp

Custom Gene Synthesis Service Market, By Application

  • Commercial
  • Academic Research

Custom Gene Synthesis Service Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Custom Gene Synthesis Service Market.

Available Customizations:

Global Custom Gene Synthesis Service Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Custom Gene Synthesis Service Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Below 1000 bp, 1001 to 3000 bp, 3001 to 5000 bp, above 5000 bp)
    • 5.2.2. By Application (Commercial, Academic Research)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Custom Gene Synthesis Service Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Custom Gene Synthesis Service Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Custom Gene Synthesis Service Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Custom Gene Synthesis Service Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Custom Gene Synthesis Service Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Custom Gene Synthesis Service Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Custom Gene Synthesis Service Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Custom Gene Synthesis Service Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Custom Gene Synthesis Service Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Custom Gene Synthesis Service Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Custom Gene Synthesis Service Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Custom Gene Synthesis Service Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Custom Gene Synthesis Service Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Custom Gene Synthesis Service Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Custom Gene Synthesis Service Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Custom Gene Synthesis Service Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Custom Gene Synthesis Service Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Custom Gene Synthesis Service Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Custom Gene Synthesis Service Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Custom Gene Synthesis Service Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Custom Gene Synthesis Service Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Custom Gene Synthesis Service Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Custom Gene Synthesis Service Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Custom Gene Synthesis Service Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Custom Gene Synthesis Service Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. GenScript Biotech Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Biomatik Corporation
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Integrated DNA Technologies, Inc.
  • 15.5. Synbio Technologies LLC
  • 15.6. Biomol GmbH
  • 15.7. Eurofins Genomics Germany GmbH
  • 15.8. BioCat GmbH
  • 15.9. Azenta US Inc.
  • 15.10. ProMab Biotechnologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer